| Announce Date | 08/07/2025 |
| EPS Normalized Actual | $1.53 (Beat by $0.91) |
| EPS GAAP Actual | $1.53 (Beat by $0.91) |
| Revenue Actual | $1.808B |
| Revenue Surprise | Beat by $1808M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.19301 |
| EPS GAAP Estimate | $1.19301 |
| Revenue Estimate | $1.76408498B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 11.15 | 13.92 | 10.29624 | 11.81171 | 1 |
| Dec 2028 | 12.46 | 12.46 | 11.95211 | 12.96209 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1.47 | 0.20715 | 1.808B | 5.81% | -37.04M |
| FQ1 2025 (Mar 2025) | 0.2 | 0.2 | 1.718B | -1.16% | 1718M |
| FQ4 2024 (Dec 2024) | -0.58 | -0.58 | 1.602B | -5.43% | 1602M |
| FQ3 2024 (Sep 2024) | 4.75 | 4.75 | 1.629B | 0.43% | 1629M |
| FQ2 2024 (Jun 2024) | 3.55 | 3.55 | 1.703B | -0.12% | 1703M |
| FQ1 2024 (Mar 2024) | 5.08 | 5.08 | 1.738B | 3.34% | 1738M |
| FQ4 2023 (Dec 2023) | 0.25 | 0.25 | 1.689B | 5.98% | 1689M |
| FQ3 2023 (Sep 2023) | 0 | 0 | 1.622B | 100% | 1622M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.19301
Consensus Revenue Estimates
1.76408498B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.15405 | -- | 1.04228 | 1.25121 | 5 |
| FQ3 2027 (Sep 2027) | 1.58227 | -- | 1.44527 | 1.65828 | 3 |
| FQ2 2027 (Jun 2027) | 1.58135 | -- | 1.44443 | 1.65731 | 5 |
| FQ1 2027 (Mar 2027) | 1.12533 | -- | 1.0279 | 1.17939 | 3 |
| FQ4 2026 (Oct 2026) | 0 | -- | 0 | 0 | 7 |
| FQ3 2026 (Jul 2026) | 0 | -- | 0 | 0 | 4 |
| FQ2 2026 (Jun 2026) | 0 | -INF | 0 | 0 | 3 |
| FQ1 2026 (Mar 2026) | 0 | -INF | 0 | 0 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.08B | -- | 1.93B | 2.22B | 8 |
| FQ3 2027 (Sep 2027) | 2B | -- | 1.87B | 2.07B | 3 |
| FQ2 2027 (Jun 2027) | 1.98B | -- | 1.85B | 2.05B | 3 |
| FQ1 2027 (Mar 2027) | 1.92B | -- | 1.79B | 1.99B | 3 |
| FQ4 2026 (Oct 2026) | 1.73B | -- | 1.62B | 1.8B | 4 |
| FQ3 2026 (Jul 2026) | 1.86B | -- | 1.74B | 1.94B | 6 |
| FQ2 2026 (Jun 2026) | 1.86B | 3.01 | 1.79B | 1.94B | 5 |
| FQ1 2026 (Mar 2026) | 1.87B | 8.11 | 1.8B | 1.95B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1.26285 | 1.47 | 0.20715 | 14.09% |
| FQ1 2025 (Mar 2025) | 0.2 | 0.2 | 100% | |
| FQ4 2024 (Dec 2024) | -0.58 | -0.58 | 100% | |
| FQ3 2024 (Sep 2024) | 4.75 | 4.75 | 100% | |
| FQ2 2024 (Jun 2024) | 3.55 | 3.55 | 100% | |
| FQ1 2024 (Mar 2024) | 5.08 | 5.08 | 100% | |
| FQ4 2023 (Dec 2023) | 0.25 | 0.25 | 100% | |
| FQ3 2023 (Sep 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $1.85B | $1.81B | $-37.04M | -2.05% |
| FQ1 2025 (Mar 2025) | $0B | $1.72B | $1718M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.6B | $1602M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.63B | $1629M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.7B | $1703M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.74B | $1738M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.69B | $1689M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $1.62B | $1622M | 100% |